KCNIP2 Gene

Migration, Crosslink

📖

KCNIP2 Gene

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-kcnip2

📖 Wiki Page

gene1824 wordssynced 2026-04-02

KCNIP2 (Potassium Voltage-Gated Channel Interacting Protein 2)

Overview

KCNIP2 (Potassium Voltage-Gated Channel Interacting Protein 2) encodes a calcium-binding protein that serves as an accessory subunit for Kv4 voltage-gated potassium channels. KCNIP2 (also known as KChIP2) is a critical modulator of neuronal excitability, cardiac repolarization, and has been implicated in neurodegenerative diseases through its effects on Kv4 channel function and calcium-dependent signaling pathways[@kcnip_neuro_cardio].

| Property | Value |
|----------|-------|
| Gene Symbol | KCNIP2 |
| Full Name | Potassium Voltage-Gated Channel Interacting Protein 2 |
| Chromosomal Location | 10q23.3 |
| NCBI Gene ID | 30818 |
| Ensembl ID | ENSG00000116096 |
| UniProt ID | Q9H0Y9 |
| Encoded Protein | KCNIP2 (KChIP2) |
| Protein Family | KCNIP family (EF-hand calcium-binding proteins) |
| Molecular Weight | ~28 kDa |

</div>

Gene Structure and Expression

Genomic Organization

The KCNIP2 gene is located on chromosome 10q23.3 and encodes a protein with multiple isoforms generated through alternative splicing. The gene contains multiple EF-hand calcium-binding domains that enable calcium-dependent regulation of Kv4 channels.

Expression Patterns

KCNIP2 exhibits a distinct expression pattern:

...

KCNIP2 (Potassium Voltage-Gated Channel Interacting Protein 2)

Overview

KCNIP2 (Potassium Voltage-Gated Channel Interacting Protein 2) encodes a calcium-binding protein that serves as an accessory subunit for Kv4 voltage-gated potassium channels. KCNIP2 (also known as KChIP2) is a critical modulator of neuronal excitability, cardiac repolarization, and has been implicated in neurodegenerative diseases through its effects on Kv4 channel function and calcium-dependent signaling pathways[@kcnip_neuro_cardio].

| Property | Value |
|----------|-------|
| Gene Symbol | KCNIP2 |
| Full Name | Potassium Voltage-Gated Channel Interacting Protein 2 |
| Chromosomal Location | 10q23.3 |
| NCBI Gene ID | 30818 |
| Ensembl ID | ENSG00000116096 |
| UniProt ID | Q9H0Y9 |
| Encoded Protein | KCNIP2 (KChIP2) |
| Protein Family | KCNIP family (EF-hand calcium-binding proteins) |
| Molecular Weight | ~28 kDa |

</div>

Gene Structure and Expression

Genomic Organization

The KCNIP2 gene is located on chromosome 10q23.3 and encodes a protein with multiple isoforms generated through alternative splicing. The gene contains multiple EF-hand calcium-binding domains that enable calcium-dependent regulation of Kv4 channels.

Expression Patterns

KCNIP2 exhibits a distinct expression pattern:

Heart: Highly expressed in ventricular myocardium, where it regulates cardiac transient outward potassium current (Ito) and action potential duration
Brain: Expressed in various brain regions including:
[Hippocampus](/brain-regions/hippocampus) — CA1, CA3 regions
[Cortex](/brain-regions/cortex) — layer 2-4 neurons
Cerebellum
Spinal cord dorsal horn
Retinal ganglion cells
Peripheral tissues: Moderate expression in smooth muscle and other tissues

Isoform Diversity

KCNIP2 has multiple isoforms with distinct subcellular localizations and functions:

Nuclear isoforms: Can act as transcriptional repressors (DREAM-like function)
Cytoplasmic isoforms: Associate with Kv4 channels at the plasma membrane
Membrane-associated isoforms: Direct Kv4 channel modulation

Protein Function and Molecular Mechanisms

Kv4 Channel Modulation

KCNIP2 is a critical accessory subunit for Kv4 channels (Kv4.1, Kv4.2, Kv4.3), which mediate the transient outward potassium current (IA) important for neuronal excitability:

Channel trafficking: KCNIP2 facilitates Kv4 channel localization to the plasma membrane

Kinetic modulation: Alters activation, inactivation, and recovery kinetics

Calcium sensing: Acts as a calcium sensor for activity-dependent channel regulation

Frequency dependence: Influences use-dependent inhibition of channel function

Calcium-Dependent Signaling

As an EF-hand calcium-binding protein, KCNIP2 participates in calcium-dependent signaling cascades:

Calmodulin-like domains: Four EF-hand motifs for calcium binding
State-dependent binding: Calcium binding is influenced by channel activity
Transcriptional regulation: Some isoforms can translocate to the nucleus and regulate gene expression (DREAM-like function)

Kv4 Channel Biology

Kv4 channels are critical for:

Repolarization: Cardiac and neuronal action potential repolarization
Excitability control: Regulation of firing thresholds and patterns
Synaptic integration: Back-propagating action potentials in dendrites
Learning and memory: Hippocampal synaptic plasticity

Disease Associations

Alzheimer's Disease

KCNIP2 and related KCNIP proteins are implicated in Alzheimer's disease through several mechanisms:

Neuronal hyperexcitability: Tau pathology leads to Kv4.2 depletion and dendritic hyperexcitability in AD models[@tau_kv42]. While KCNIP2 specifically hasn't been studied in detail, the Kv4 channel complex is affected.

Kv4 channel dysfunction: Voltage-gated potassium channels are affected by oxidative stress in aging and neurodegeneration[@kv_channel_neuro].

Resilience signatures: Single-cell omics studies identified KCNIP4 (a related family member) as associated with resilient neurons in AD[@kcnip4_resilience], suggesting KCNIP family members may play protective roles.

Neuronal excitability: Loss of DPP6 (another Kv4 accessory protein) increases risk for early-onset Alzheimer's through neuronal excitability dysfunction[@dpp6_dementia]. KCNIP2 may have similar effects.

Parkinson's Disease

Kv4 channel blockade: Kv4 channel blockade in the striatum reduces motor and neuropsychiatric symptoms in PD models[@kv4_pd], suggesting Kv4/KCNIP2 complex may be a therapeutic target.

Dopaminergic signaling: Kv4 channels regulate dopaminergic neuron excitability and could influence PD pathogenesis.

Non-motor symptoms: KCNIP2 dysfunction may contribute to neuropsychiatric symptoms in PD.

Epilepsy

Altered expression: KCNIP2 expression is altered in epileptic tissue, potentially contributing to neuronal hyperexcitability.

Channel dysfunction: Kv4 channel dysregulation is implicated in seizure susceptibility.

Therapeutic target: KCNIP2 modulators may have anti-epileptic potential.

Cardiac Arrhythmias

KCNIP2 mutations are associated with cardiac arrhythmias:

Brugada syndrome: Gain-of-function mutations can alter action potential duration
Early repolarization syndrome: Associated with KCNIP2 variants
Long QT syndrome: Some KCNIP2 variants affect cardiac repolarization[@kcnip2_arrhythmia]

Neuropathic Pain

KCNIP2 is involved in sensory neuron excitability and pain signaling:

Dorsal horn KCNIP2-expressing inhibitory interneurons control cold sensitivity[@kcnip2_cold]
May contribute to chronic pain states

Retinal Degeneration

KCNIP2 serves as a molecular marker for OFF-transient alpha retinal ganglion cells[@kcnip2_rgc], which are involved in visual processing and may be affected in retinal degenerations.

Molecular Mechanisms in Neurodegeneration

Excitotoxicity

Kv4 channel dysfunction can contribute to excitotoxic cell death:

Impaired repolarization leads to prolonged depolarization
Increased calcium influx through voltage-gated calcium channels
Activation of pro-apoptotic signaling pathways

Oxidative Stress

KCNIP proteins may be affected by oxidative stress in neurodegeneration:

Oxidative modification of EF-hand domains
Altered calcium binding kinetics
Impaired channel trafficking

Synaptic Dysfunction

Kv4 channels regulate synaptic plasticity:

Back-propagating action potentials
Dendritic integration
Long-term potentiation and depression

Mitochondrial Dysfunction Interactions

KCNIP2 may interact with mitochondrial dysfunction in neurodegeneration:

Energy metabolism: Neuronal excitability requires ATP, and mitochondrial dysfunction in AD/PD affects energy supply

Calcium homeostasis: Both KCNIP2 and mitochondria handle calcium, and their dysfunction can lead to apoptotic signaling

Oxidative stress: Mitochondrial ROS can modify KCNIP2 protein function

Neuroinflammation Connections

The neuroinflammatory environment in neurodegenerative diseases affects KCNIP2:

Cytokine signaling: Inflammatory cytokines can alter ion channel expression

Microglial activation: KCNIP2 expression in neurons may be affected by microglial signaling

Blood-brain barrier: Inflammatory changes may affect KCNIP2 function

Protein-Protein Interactions

Kv4 Channel Complex

KCNIP2 forms a stoichiometric complex with Kv4 α-subunits:

Kv4.1 (KCND1): Widely expressed in the nervous system

Kv4.2 (KCND2): Major neuronal Kv4 subunit, highly expressed in hippocampus and cortex

Kv4.3 (KCND3): Expressed in heart and brain

Auxiliary Proteins

The Kv4 channel complex includes multiple auxiliary subunits:

DPP6 (DPPX): Regulates channel trafficking and kinetics

DPP10: Alternative auxiliary subunit with distinct expression

KCNIP proteins: Calcium-dependent modulation

Signaling Interactions

KCNIP2 interacts with multiple signaling pathways:

Calmodulin-dependent protein kinases: CaMKII phosphorylation affects Kv4 function

PKA/PKC signaling: Channel phosphorylation regulates current properties

ERK/MAPK pathway: Activity-dependent modulation

Genetic Variants and Polymorphisms

Known Variants

KCNIP2 genetic variants have been associated with:

Cardiac arrhythmic disorders: Multiple variants affect cardiac repolarization

Neurological conditions: Potential associations with epilepsy and neurodegeneration

Pain disorders: Variants may influence pain sensitivity

Population Genetics

Minor allele frequencies vary across populations
Some variants may confer selective advantages
Functional significance of most polymorphisms remains unknown

Therapeutic Implications

Kv4 Channel Modulators

Activators: Enhance Kv4 channel function to reduce excitability

Blockers: Reduce Kv4 function to treat hyperexcitability disorders

Small Molecule Approaches

Multiple pharmaceutical companies have developed Kv4 modulators:

Amino acid derivatives: Modify channel gating kinetics

Pyridine derivatives: Target specific channel subunits

Natural products: Plant-derived compounds with Kv4 activity

KCNIP2-Targeted Approaches

Peptide-based disruptors of KCNIP2-Kv4 interaction
Small molecules stabilizing KCNIP2-Kv4 complexes
Gene therapy approaches for specific KCNIP2 isoforms

Combination Therapies

KCNIP2-based therapies may be combined with:

Acetylcholinesterase inhibitors: For AD cognitive symptoms

Dopaminergic therapies: For PD motor symptoms

Anti-epileptic drugs: For seizure control

Clinical Relevance

While no KCNIP2-targeted therapies are currently approved, the protein represents a potential target for:

Alzheimer's disease (excitability normalization)
Parkinson's disease (motor and non-motor symptoms)
Epilepsy (seizure control)
Cardiac arrhythmias (repolarization normalization)

Research Directions

Emerging Areas

Single-cell transcriptomics: Understanding KCNIP2 expression in specific neuronal subtypes

Structural biology: KCNIP2-Kv4 channel complex structure for drug design

Biomarkers: KCNIP2 variants as genetic risk factors

Animal models: Conditional knockout studies in neurons and cardiac cells

Key Unanswered Questions

What is the precise role of neuronal KCNIP2 in AD/PD pathogenesis?
Can KCNIP2 modulation provide neuroprotection?
What are the isoform-specific functions in different cell types?
How does KCNIP2 cross-talk with other neurodegeneration pathways?

Animal Models

Knockout Models

Kcnip2 knockout mice have been generated and characterized:

Cardiac phenotype: Altered cardiac repolarization and increased arrhythmia susceptibility

Neural phenotype: Changes in neuronal excitability and learning/memory deficits

Behavioral studies: Altered responses to environmental stimuli

Transgenic Models

Transgenic overexpression models have been developed to study:

Gain-of-function effects: Impact on neuronal excitability

Disease models: Crossbreeding with AD/PD models

Rescue studies: Therapeutic potential of KCNIP2 modulation

Disease Model Studies

KCNIP2 has been studied in various animal models:

Parkinson's disease models: MPTP-treated mice show altered Kv4 channel function

Alzheimer's disease models: APP/PS1 mice show altered KCNIP expression

Epilepsy models: Kcnip2 expression changes in seizure models

Summary

KCNIP2 encodes a critical accessory subunit for Kv4 voltage-gated potassium channels, modulating neuronal and cardiac excitability. The protein has been implicated in Alzheimer's disease, Parkinson's disease, epilepsy, and cardiac arrhythmias through its effects on Kv4 channel function. While specific research on KCNIP2 in neurodegeneration is limited, the broader literature on Kv4 channels and related KCNIP family members supports a role in neuronal excitability dysfunction in AD and PD. KCNIP2 represents a potential therapeutic target for modulating neuronal excitability in neurodegenerative diseases.

References

[K(V) Channel-Interacting Proteins in the Neurological and Cardiovascular Systems (PMID:37508558)](https://pubmed.ncbi.nlm.nih.gov/37508558/)

[Inhibitory Kcnip2 neurons of the spinal dorsal horn control behavioral sensitivity to environmental cold (PMID:36323322)](https://pubmed.ncbi.nlm.nih.gov/36323322/)

[OFF-transient alpha RGCs mediate looming triggered innate defensive response (PMID:33798432)](https://pubmed.ncbi.nlm.nih.gov/33798432/)

[Ca(2+)-Dependent Transcriptional Repressors KCNIP and Regulation of Prognosis Genes in Glioblastoma (PMID:30618619)](https://pubmed.ncbi.nlm.nih.gov/30618619/)

[Subcellular localization and transcription regulatory potency of KCNIP proteins in neurons (PMID:22612322)](https://pubmed.ncbi.nlm.nih.gov/22612322/)

[Structure, alternative splicing, and expression of the human and mouse KCNIP gene family (PMID:16112838)](https://pubmed.ncbi.nlm.nih.gov/16112838/)

[Kv4 channel blockade reduces motor and neuropsychiatric symptoms in PD (PMID:25356731)](https://pubmed.ncbi.nlm.nih.gov/25356731/)

[Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in AD (PMID:25878292)](https://pubmed.ncbi.nlm.nih.gov/25878292/)

[Loss of DPP6 in neurodegenerative dementia (PMID:30874922)](https://pubmed.ncbi.nlm.nih.gov/30874922/)

[Molecular Signatures of Resilience to Alzheimer's Disease (PMID:39574639)](https://pubmed.ncbi.nlm.nih.gov/39574639/)

[Therapeutic role of voltage-gated potassium channels in age-related neurodegenerative diseases (PMID:38827782)](https://pubmed.ncbi.nlm.nih.gov/38827782/)

[KCNIP2 mutations in cardiac arrhythmias (PMID:26637639)](https://pubmed.ncbi.nlm.nih.gov/26637639/)

[Kv4.2 potassium channels and hippocampal memory (PMID:25819076)](https://pubmed.ncbi.nlm.nih.gov/25819076/)

[DREAM in pain and cognition (PMID:25962962)](https://pubmed.ncbi.nlm.nih.gov/25962962/)

[Solution structure of the EF-hand domain of KCNIP2 (PMID:18614095)](https://pubmed.ncbi.nlm.nih.gov/18614095/)

[Subunit composition of native neuronal Kv4 channels (PMID:12842086)](https://pubmed.ncbi.nlm.nih.gov/12842086/)

[Kv4 channel auxiliary subunits in neuronal excitability and disease (PMID:34168237)](https://pubmed.ncbi.nlm.nih.gov/34168237/)

[Calcium binding protein regulation of ion channels in disease (PMID:33074289)](https://pubmed.ncbi.nlm.nih.gov/33074289/)

[Neuronal potassium channels in synaptic plasticity and memory (PMID:28793252)](https://pubmed.ncbi.nlm.nih.gov/28793252/)

[Ion channel dysfunction in Alzheimer's disease models (PMID:29249657)](https://pubmed.ncbi.nlm.nih.gov/29249657/)

External Links

[Ensembl: ENSG00000116096](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116096)
[NCBI Gene: KCNIP2](https://www.ncbi.nlm.nih.gov/gene/?term=KCNIP2)
[GeneCards: KCNIP2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNIP2)
[UniProt: Q9H0Y9](https://www.uniprot.org/uniprot/Q9H0Y9)

📖 View canonical wiki page →

Related Entities

KCNIP2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-kcnip2
kg_node_id	KCNIP2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-809096ee90a4
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-kcnip2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

6

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

KCNIP2 Gene

KCNIP2 (Potassium Voltage-Gated Channel Interacting Protein 2)

Overview

Gene Structure and Expression

Genomic Organization

Expression Patterns

KCNIP2 (Potassium Voltage-Gated Channel Interacting Protein 2)

Overview

Gene Structure and Expression

Genomic Organization

Expression Patterns

Isoform Diversity

Protein Function and Molecular Mechanisms

Kv4 Channel Modulation

Calcium-Dependent Signaling

Kv4 Channel Biology

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Cardiac Arrhythmias

Neuropathic Pain

Retinal Degeneration

Molecular Mechanisms in Neurodegeneration

Excitotoxicity

Oxidative Stress

Synaptic Dysfunction

Mitochondrial Dysfunction Interactions

Neuroinflammation Connections

Protein-Protein Interactions

Kv4 Channel Complex

Auxiliary Proteins

Signaling Interactions

Genetic Variants and Polymorphisms

Known Variants

Population Genetics

Therapeutic Implications

Kv4 Channel Modulators

Small Molecule Approaches

KCNIP2-Targeted Approaches

Combination Therapies

Clinical Relevance

Research Directions

Emerging Areas

Key Unanswered Questions

Animal Models

Knockout Models

Transgenic Models

Disease Model Studies

Summary

See Also

References

External Links

💬 Discussion